IL33 and chronic obstructive pulmonary disease: When GW4869 was tested against the panel of IL-33 variants in COPD cells, it was found to globally inhibit secretion for variants that exhibit distinct cellular localization patterns and expression levels (Figure 2B and Supplemental Figure 2C).